HUMMINGBIRD BIOSCIENCE
LIVE

Serial Number

79344027

Owner

Hummingbird Bioscience Pte. Ltd.

Attorney

Maren C. Perry

Filing Date

May 24, 2022

Add to watchlist:

No watchlists yet
View on USPTO

HUMMINGBIRD BIOSCIENCE Trademark

Serial Number: 79344027 • Registration: 7764191

HUMMINGBIRD BIOSCIENCE is a trademark filed by Hummingbird Bioscience Pte. Ltd. on May 24, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Hummingbird Bioscience Pte. Ltd.

#04-01/11, The Aries,

Entity Type: 24

Trademark Details

Filing Date

May 24, 2022

Registration Date

April 22, 2025

Published for Opposition

March 4, 2025

Goods & Services

Pharmaceutical preparations for the prevention, diagnosis, and treatment of oncological and immune system diseases for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical and biological preparations for use in the treatment of biological disorders for oncological and immune system diseases; pharmaceutical preparations for therapeutic interventions, namely, therapeutic agents to treat oncological and immune systems diseases ; biological preparations for the treatment of biological disorders for oncological and immune system diseases; anti-cancer drugs; biological preparations for the treatment of cancer; immunological antibodies for medical use; monoclonal antibodies for medical use, monoclonal antibodies for therapeutic purposes; preparations containing antibodies for use in medicine; reagents for use in the development of monoclonal antibodies for medical purposes

Medical research, medical research services; scientific research for medical purposes in the area of cancerous drugs; biomedical research services; drug discovery services; scientific and technological research and design in the field of medical biotechnology; scientific and technological industrial analysis and research services; scientific research in the development of new therapies to treat biological disorders; scientific research for the medical purposes in the area of cancerous diseases; research and development services in the field of antibodies

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 30, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 6, 2025 FICS
FINAL DISPOSITION PROCESSED
Nov 6, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 22, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 22, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 22, 2025 R.PR
PUBLISHED FOR OPPOSITION
Mar 4, 2025 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2025 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2025 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 10, 2025 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 7, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 16, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 18, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 18, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 18, 2024 CNRT
ASSIGNED TO LIE
Jun 12, 2024 ALIE
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 11, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 15, 2024 ERSI
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 25, 2023 OPNX
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 22, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 22, 2023 GNSL
SUSPENSION LETTER WRITTEN
Dec 22, 2023 CNSL
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 6, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 6, 2023 OPNR
ASSIGNED TO EXAMINER
Nov 6, 2023 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 3, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 3, 2023 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jun 9, 2023 NREP
REFUSAL PROCESSED BY IB
May 23, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 4, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 4, 2023 RFRR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 26, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 26, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 26, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 26, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 26, 2023 COAR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 17, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 16, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 13, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 12, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 6, 2022 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 1, 2022 SDRC